Title:
ＮａＰｉ−ＩＩｂ阻害剤として有用な縮合チオフェン誘導体
Document Type and Number:
Japanese Patent JP6653410
Kind Code:
B2
Abstract:
The invention provides compounds of the formula: (A), pharmaceutically acceptable salts, pharmaceutical compositions thereof, and methods of using these compounds, salts, or compositions to treat hyperphosphatemia, chronic kidney disease, and/or the cardiovascular diease associated with chronic kidney disease.
More Like This:
| JP2010508303 | Liquid formulation of phospholipase enzyme inhibitor |
| JPS62148470 | SELECTIVE HERBICIDE |
| WO/2003/024949 | DNA-PK INHIBITORS |
Inventors:
David Andrew Coates
Kevin Robert Fails
Jeffrey Alan Peterson
Jeffrey Michael Skaryantz
Quan Long Shen
Matthew John Bali
John Laurie Wetello The Second
Dariush Stanislow Vodka
Yampin Shoe
Kevin Robert Fails
Jeffrey Alan Peterson
Jeffrey Michael Skaryantz
Quan Long Shen
Matthew John Bali
John Laurie Wetello The Second
Dariush Stanislow Vodka
Yampin Shoe
Application Number:
JP2019527785A
Publication Date:
February 26, 2020
Filing Date:
August 08, 2017
Export Citation:
Assignee:
Eli Lilly and Company
International Classes:
C07D409/12; A61K9/20; A61K31/496; A61K31/4995; A61K47/32; A61P3/00; A61P9/00; A61P13/12; C07D487/08
Domestic Patent References:
| JP2013107880A |
Foreign References:
| WO2016026372A1 | ||||
| WO2014003153A1 | ||||
| WO2011136269A1 |
Attorney, Agent or Firm:
Norihito Yamao
Nagatoshi Shinagawa
Kure Hidenori
Kamahira Futami
Mizuhara Masahiro
Nagatoshi Shinagawa
Kure Hidenori
Kamahira Futami
Mizuhara Masahiro